200 µl viral stock containing 1x 10(6) infectious units of virus (IFU) , sufficient for 10-20 transductions. Provided as transduction-ready viral particles for gene silencing in human cells. Generally contain three to five expression constructs each encoding target-specific 19-25 nt (plus hairpin) shRNA designed to knockdown gene expression in human cells. After transduction, stable cell lines expressing the shRNA may be isolated via selection with puromycin. Biosafety:Lentiviral Particles are replication-incompetent and are designed to self-inactivate after transduction and integration of shRNA constructs into genomic DNA of target cells.
shRNA Lentiviral Particles are provided as pools of three to five expression constructs each encoding target-specific 19-25 nt (plus hairpin loop) shRNA designed to knockdown gene expression. Provided as 200 μl transduction-ready viral particles, sufficient for 10-20 transductions. Replication-incompetent and are designed to self-inactivate after transduction and integration of shRNA constructs into genomic DNA of target cells (puromycin-selection). Suitable control antibodies and RT-PCR primers are available for monitoring gene expression knockdown.
shRNA Lentiviral Particles are provided as pools of three to five expression constructs each encoding target-specific 19-25 nt (plus hairpin loop) shRNA designed to knockdown gene expression. Provided as 200 μl transduction-ready viral particles, sufficient for 10-20 transductions. Replication-incompetent and are designed to self-inactivate after transduction and integration of shRNA constructs into genomic DNA of target cells (puromycin-selection). Suitable control antibodies and RT-PCR primers are available for monitoring gene expression knockdown.
shRNA Lentiviral Particles are provided as pools of three to five expression constructs each encoding target-specific 19-25 nt (plus hairpin loop) shRNA designed to knockdown gene expression. Provided as 200 μl transduction-ready viral particles, sufficient for 10-20 transductions. Replication-incompetent and are designed to self-inactivate after transduction and integration of shRNA constructs into genomic DNA of target cells (puromycin-selection). Suitable control antibodies and RT-PCR primers are available for monitoring gene expression knockdown.
shRNA Lentiviral Particles are provided as pools of three to five expression constructs each encoding target-specific 19-25 nt (plus hairpin loop) shRNA designed to knockdown gene expression. Provided as 200 μl transduction-ready viral particles, sufficient for 10-20 transductions. Replication-incompetent and are designed to self-inactivate after transduction and integration of shRNA constructs into genomic DNA of target cells (puromycin-selection). Suitable control antibodies and RT-PCR primers are available for monitoring gene expression knockdown.
200 µl viral stock containing 1x 10(6) infectious units of virus (IFU) , sufficient for 10-20 transductions. Provided as transduction-ready viral particles for gene silencing in mouse cells. Generally contain three to five expression constructs each encoding target-specific 19-25 nt (plus hairpin) shRNA designed to knockdown gene expression in mouse cells. After transduction, stable cell lines expressing the shRNA may be isolated via selection with puromycin. Biosafety:Lentiviral Particles are replication-incompetent and are designed to self-inactivate after transduction and integration of shRNA constructs into genomic DNA of target cells.
200 µl viral stock containing 1x 10(6) infectious units of virus (IFU) , sufficient for 10-20 transductions. Provided as transduction-ready viral particles for gene silencing in human cells. Generally contain three to five expression constructs each encoding target-specific 19-25 nt (plus hairpin) shRNA designed to knockdown gene expression in human cells. After transduction, stable cell lines expressing the shRNA may be isolated via selection with puromycin. Biosafety:Lentiviral Particles are replication-incompetent and are designed to self-inactivate after transduction and integration of shRNA constructs into genomic DNA of target cells.
粤公网安备 44010602000434号
